Amosulalol hydrochloride long acting formulations

Details Amosulalol hydrochloride long acting formulations Amosulalol hydrochloride long acting formulations

1987-05-05

1988-08-23

Rose, Shep K.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Tablets, lozenges, or pills

424474, 424480, 424482, A61K 932, A61K 936, A61K 934

Patent

active

047659882

ABSTRACT:
Long acting formulations of amosulalol hydrochloride are provided, wherein the frequency of administering the hypotensive agent is minimized and wherein such formulations are prepared by compounding amosulalol hydrochloride with an enterosoluble material and optionally the inclusion of an organic acid.

REFERENCES:
patent: 3520970 (1970-07-01), Lehmann et al.
patent: 3538214 (1970-11-01), Polli et al.
patent: 3775537 (1973-11-01), Lehmann et al.
patent: 3835221 (1974-09-01), Fulberth et al.
patent: 3954959 (1976-05-01), Pedersen
patent: 4083949 (1978-04-01), Benedikt
patent: 4289750 (1981-09-01), Kopp et al.
patent: 4361546 (1982-11-01), Stricker et al.
patent: 4367217 (1983-01-01), Gruber et al.
patent: 4427648 (1984-01-01), Brickl et al.
patent: 4438091 (1984-03-01), Gruber et al.
patent: 4724148 (1988-02-01), Sonobe et al.

Affiliated with

Also associated with

Rating

Amosulalol hydrochloride long acting formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Amosulalol hydrochloride long acting formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amosulalol hydrochloride long acting formulations will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-835083